PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,847 | +28.6% | 209,054 | +4.2% | 0.00% | – |
| Q2 2023 | $230,826 | +124000.0% | 200,719 | +14.4% | 0.00% | – |
| Q1 2023 | $186 | -20.5% | 175,383 | +14.1% | 0.00% | – |
| Q4 2022 | $234 | -99.9% | 153,698 | +4.5% | 0.00% | – |
| Q3 2022 | $312,000 | +74.3% | 147,041 | +10.1% | 0.00% | – |
| Q2 2022 | $179,000 | -13.9% | 133,547 | +35.5% | 0.00% | – |
| Q1 2022 | $208,000 | -43.9% | 98,545 | -1.5% | 0.00% | – |
| Q4 2021 | $371,000 | -27.1% | 100,026 | -2.0% | 0.00% | -100.0% |
| Q3 2021 | $509,000 | -20.6% | 102,095 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $641,000 | +3.7% | 98,358 | +9.6% | 0.00% | 0.0% |
| Q1 2021 | $618,000 | -37.2% | 89,761 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $984,000 | +215.4% | 96,436 | +8.1% | 0.00% | – |
| Q3 2020 | $312,000 | -38.6% | 89,201 | -12.4% | 0.00% | -100.0% |
| Q2 2020 | $508,000 | +33.3% | 101,871 | -9.0% | 0.00% | 0.0% |
| Q1 2020 | $381,000 | – | 111,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |